Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
- PMID: 34220507
- PMCID: PMC8248548
- DOI: 10.3389/fphar.2021.669642
Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
Abstract
The coronavirus disease 2019 (COVID-19) has spread widely around the world and has seriously affected the human health of tens of millions of people. In view of lacking anti-virus drugs target to SARS-CoV-2, there is an urgent need to develop effective new drugs. In this study, we reported our discovery of SARS-CoV-2 Mpro inhibitors. We selected 15 natural compounds, including 7 flavonoids, 3 coumarins, 2 terpenoids, one henolic, one aldehyde and one steroid compound for molecular docking and enzymatic screening. Myricetin were identified to have potent inhibit activity with IC50 3.684 ± 0.076 μM in the enzyme assay. The binding pose of Myricetin with SARS-CoV-2 Mpro was identified using molecular docking method. In the binding pocket of SARS-CoV-2 Mpro, the chromone ring of Myricetin interacts with His41 through π-π stacking, and the 3'-, 4'- and 7-hydroxyl of Myricetin interact with Phe140, Glu166and Asp187 through hydrogen bonds. Significantly, our results showed that Myricetin has potent effect on bleomycin-induced pulmonary inflammation by inhibiting the infiltration of inflammatory cells and the secretion of inflammatory cytokines IL-6, IL-1α, TNF-α and IFN-γ. Overall, Myricetin may be a potential drug for anti-virus and symptomatic treatment of COVID-19.
Keywords: 3CLpro (Mpro); COVID-19; SARS-CoV-2; myricetin; pulmonary inflammation.
Copyright © 2021 Xiao, Cui, Zheng, Wang, Sun, Gao, Bao, Ren, Yang, Lin, Li, Li, Yang and Zhou.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis.Phytomedicine. 2021 Oct;91:153704. doi: 10.1016/j.phymed.2021.153704. Epub 2021 Aug 8. Phytomedicine. 2021. PMID: 34419736 Free PMC article.
-
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.Viruses. 2022 Jun 30;14(7):1458. doi: 10.3390/v14071458. Viruses. 2022. PMID: 35891437 Free PMC article.
-
Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro.Front Mol Biosci. 2020 Dec 23;7:613401. doi: 10.3389/fmolb.2020.613401. eCollection 2020. Front Mol Biosci. 2020. PMID: 33425994 Free PMC article.
-
Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors.Eur J Med Chem Rep. 2022 Apr;4:100034. doi: 10.1016/j.ejmcr.2022.100034. Epub 2022 Feb 10. Eur J Med Chem Rep. 2022. PMID: 37519829 Free PMC article.
-
2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.Chem Biol Interact. 2021 Feb 1;335:109348. doi: 10.1016/j.cbi.2020.109348. Epub 2020 Dec 2. Chem Biol Interact. 2021. PMID: 33278462 Free PMC article.
Cited by
-
Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro.Inflammopharmacology. 2024 Oct;32(5):3007-3035. doi: 10.1007/s10787-024-01525-9. Epub 2024 Jul 24. Inflammopharmacology. 2024. PMID: 39048773 Review.
-
Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics.Acta Pharm Sin B. 2024 May;14(5):2349-2357. doi: 10.1016/j.apsb.2024.03.001. Epub 2024 Mar 6. Acta Pharm Sin B. 2024. PMID: 38799620 Free PMC article.
-
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds.Pharmaceuticals (Basel). 2021 Sep 1;14(9):892. doi: 10.3390/ph14090892. Pharmaceuticals (Basel). 2021. PMID: 34577592 Free PMC article.
-
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review.Clin Pharmacol. 2024 Jan 4;16:1-25. doi: 10.2147/CPAA.S429064. eCollection 2024. Clin Pharmacol. 2024. PMID: 38197085 Free PMC article. Review.
-
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2.Biomolecules. 2024 Jan 19;14(1):130. doi: 10.3390/biom14010130. Biomolecules. 2024. PMID: 38275759 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous